Oral Genome, a leader in dental health innovation, has partnered with the Community Health Center of Snohomish County (CHC) and Washington Dental Service (WDS) to pilot a groundbreaking saliva testing program aimed at enhancing preventive oral healthcare. This initiative introduces Oral Genome’s advanced saliva testing kits into school-based health centers and traditional dental settings in Snohomish County.
The Oral Genome kits provide rapid assessments of oral health risks, including caries, periodontal disease, and diabetes, enabling early detection and proactive care. This pilot aims to bridge the gap between preventive care and intensive treatments, offering underserved populations access to cutting-edge dental technologies.
“We believe in the transformative power of innovative technologies like those from Oral Genome,” said Glenn Puckett, project lead for WDS. “This pilot will help us gather critical data on improving patient care and integrating these tools into benefit designs.”
Integrating GLP-1s: How Berry Street is Redefining Nutrition Care
Richard Fu details the company's approach to nutrition therapy and strategy for patients using GLP-1s.
Dr. Sue Yoon, CHC’s chief dental officer, highlighted the initiative’s impact: “Implementing Oral Genome testing kits is a significant step towards accessible and effective preventive oral healthcare.”
Dr. Tina Saw, founder of Oral Genome, expressed her excitement: “This pilot has the potential to revolutionize preventive dental care and significantly improve overall health outcomes.”
The pilot underscores Oral Genome’s commitment to advancing oral health knowledge and integrating new technologies into existing healthcare frameworks, ultimately enhancing patient engagement and preventive care.
Enhanced Direct Enrollment: Georgia Access and the Power of Partnership
Across the nation, state-based health insurance exchanges are searching for ways to better serve their communities while making enrollment easier, more personal, and more accessible for everyone.
Noetik, an AI biotech company using self-supervised machine learning and high-throughput spatial data to develop next-generation cancer therapeutics, has closed an oversubscribed $40 million Series A financing round, according to a press release.
Polaris Partners and managing partner Amy Schulman led the round. Schulman will join the board of directors. New investors that participated in the funding round include Khosla Ventures, Wittington Ventures and Breakout Ventures. The round was also supported by existing investors DCVC, Zetta Venture Partners, Catalio Capital Management, 11.2 Capital, Epic Ventures, Intermountain Ventures and North South Ventures, according to a press release.
“We are thrilled to have the support of incredible investors who share our vision of combining deep patient data and artificial intelligence to build the future of cancer therapeutics. This significant financing will enable us to accelerate our progress toward turning biological insights into a portfolio of therapeutic candidates,” said Dr. Ron Alfa, Noetik CEO and co-founder.
To read more, click here.
BeMe Health, a pioneering digital behavioral health startup focusing on teen mental health, has raised more than $12 million in funding to support growth in the runup to a Series A round, according to a press release. The funding from Hesperia Capital makes BeMe Health its latest portfolio company. BeMe’s investors include Flare Capital, Polaris Partners, Fiore Ventures, and the California Health Care Foundation.
BeMe works with health plans, employers, and community organizations to provide a digital-first approach to interventional teen mental health.
To learn more, click here.
Vouched, a startup that specializes in AI-powered identity verification for healthcare, banking and financial services, has hired Peter Horadan as its new CEO. Horadan previously founded and led Lockstep, an accounting tech platform, before The Sage Group acquired it. Vouched’s founder John Baird will become the board chairman and Chief Strategy Officer for the business, according to a press release.
“Identity verification is foundational to online interactions in healthcare, commerce, and cybersecurity,” said Horadan in a press release. “Vouched’s computer vision technology and AI-driven fraud detection models are solving the most complex global identity verification challenges today, and I look forward to building on the company’s strong foundation for this next phase of rapid growth and innovation.”
To learn more, click here.
Photo: Urupong, Getty Images
This is a paid member feature of MedCitizens. Please submit here and join!